TELA Bio, Inc. TELA
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.22% | -8.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.22% | -8.67% | |||
| Cost of Revenue | -18.48% | -8.19% | |||
| Gross Profit | 11.28% | -8.92% | |||
| SG&A Expenses | -0.97% | 13.29% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.42% | 7.52% | |||
| Operating Income | 11.81% | -58.33% | |||
| Income Before Tax | 8.28% | -37.29% | |||
| Income Tax Expenses | 0.00% | -58.62% | |||
| Earnings from Continuing Operations | 8.24% | -35.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.24% | -35.75% | |||
| EBIT | 11.81% | -58.33% | |||
| EBITDA | 12.13% | -59.77% | |||
| EPS Basic | 8.49% | -22.58% | |||
| Normalized Basic EPS | 8.55% | -37.71% | |||
| EPS Diluted | 8.49% | -22.58% | |||
| Normalized Diluted EPS | 8.55% | -37.71% | |||
| Average Basic Shares Outstanding | 0.28% | 10.78% | |||
| Average Diluted Shares Outstanding | 0.28% | 10.78% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||